Iridium-192 Production for Cancer Treatment

PDF Version Also Available for Download.

Description

The purpose of this work is to settle a laboratory for Iridium -192 sources production, that is, to determine a wire activation method and to build a hot cell for the wires manipulation, quality control and packaging. The paper relates, mainly, the wire activation method and its quality control. The wire activation is carried out in our nuclear reactor, IEA- R1m.

Physical Description

vp.

Creation Information

Rostelato, M.E.C.M.; Silva, C.P.G.; Rela, P.R.; Zeituni, C.A.; Lepki, V. & Feher, A. October 5, 2004.

Context

This article is part of the collection entitled: Office of Scientific & Technical Information Technical Reports and was provided by UNT Libraries Government Documents Department to Digital Library, a digital repository hosted by the UNT Libraries. More information about this article can be viewed below.

Who

People and organizations associated with either the creation of this article or its content.

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

Contact Us

What

Descriptive information to help identify this article. Follow the links below to find similar items on the Digital Library.

Description

The purpose of this work is to settle a laboratory for Iridium -192 sources production, that is, to determine a wire activation method and to build a hot cell for the wires manipulation, quality control and packaging. The paper relates, mainly, the wire activation method and its quality control. The wire activation is carried out in our nuclear reactor, IEA- R1m.

Physical Description

vp.

Notes

INIS; OSTI as DE00840203

Source

  • Americas Nuclear Energy Symposium (ANES 2004), Miami, FL (US), 10/03/2004--10/06/2004

Language

Item Type

Identifier

Unique identifying numbers for this article in the Digital Library or other systems.

  • Report No.: none
  • Office of Scientific & Technical Information Report Number: 840203
  • Archival Resource Key: ark:/67531/metadc785988

Collections

This article is part of the following collection of related materials.

Office of Scientific & Technical Information Technical Reports

What responsibilities do I have when using this article?

When

Dates and time periods associated with this article.

Creation Date

  • October 5, 2004

Added to The UNT Digital Library

  • Dec. 3, 2015, 9:30 a.m.

Description Last Updated

  • Jan. 22, 2016, 5:28 p.m.

Usage Statistics

When was this article last used?

Yesterday: 0
Past 30 days: 0
Total Uses: 2

Interact With This Article

Here are some suggestions for what to do next.

Start Reading

PDF Version Also Available for Download.

Citations, Rights, Re-Use

Rostelato, M.E.C.M.; Silva, C.P.G.; Rela, P.R.; Zeituni, C.A.; Lepki, V. & Feher, A. Iridium-192 Production for Cancer Treatment, article, October 5, 2004; United States. (digital.library.unt.edu/ark:/67531/metadc785988/: accessed August 19, 2017), University of North Texas Libraries, Digital Library, digital.library.unt.edu; crediting UNT Libraries Government Documents Department.